mRNA |
salermide:PLX-4032 (12:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.05 |
mRNA |
AT-406 |
CTRPv2 |
pan-cancer |
AAC |
0.092 |
0.05 |
mRNA |
BRD-K49290616 |
CTRPv2 |
pan-cancer |
AAC |
-0.15 |
0.06 |
mRNA |
alisertib:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.066 |
0.06 |
mRNA |
SMER-3 |
CTRPv2 |
pan-cancer |
AAC |
-0.072 |
0.06 |
mRNA |
Methotrexate |
CTRPv2 |
pan-cancer |
AAC |
0.068 |
0.06 |
mRNA |
QW-BI-011 |
CTRPv2 |
pan-cancer |
AAC |
-0.13 |
0.07 |
mRNA |
ISOX |
CTRPv2 |
pan-cancer |
AAC |
-0.057 |
0.07 |
mRNA |
Repligen 136 |
CTRPv2 |
pan-cancer |
AAC |
-0.065 |
0.08 |
mRNA |
necrosulfonamide |
CTRPv2 |
pan-cancer |
AAC |
-0.068 |
0.08 |